Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12617001353381Phase 3Recruiting
Phase 3, open-label trial of propofol and sevoflurane in Dorsalgia (2 arms), sponsored by Samuel Boyers. Primary endpoint: Change in Quality of Recovery-40 score. Started Jan 2017; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12617001353381.